Search results for "Early Diagnosis"

showing 10 items of 123 documents

Chemotherapy cardiotoxicity: cardioprotective drugs and early identification of cardiac dysfunction.

2016

Background: Chemotherapy cardiotoxicity is an emerging problem and it is very important to prevent cardiac dysfunction caused by anticancer drugs. The aim of this study was to assess the alterations of the cardiac function induced by chemotherapy in a follow-up of 2 years and to evaluate the cardioprotective role of angiotensin-converting enzyme inhibitors (ACEIs) in the prevention of cardiac dysfunction. Methods: A prospective study was carried out using patients with breast cancer (85 women; median age 57W12years) and other inclusion and exclusion criteria. On the basis of treatment, patients were divided into six groups: fluorouracil-epirubicincyclophosphamide, FEC (group A); FEC and tra…

Cardiac function curveAdultmedicine.medical_specialtyCardiotonic Agentsmedicine.medical_treatmentAngiotensin-Converting Enzyme InhibitorsBreast Neoplasms030204 cardiovascular system & hematologyBioinformaticsCardiac dysfunctionAngiotensin-converting enzyme inhibitor; Cardiotoxicity; Chemotherapy; Prevention; Tissue Doppler imaging; Adult; Aged; Aged 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiotonic Agents; Cardiotoxicity; Early Diagnosis; Echocardiography Doppler; Female; Follow-Up Studies; Humans; Middle Aged; Prospective Studies03 medical and health sciencesTissue Doppler imaging0302 clinical medicinecardiac toxicity anti cancer drugs cardiac dysfunctionInternal medicineAntineoplastic Combined Chemotherapy Protocols80 and overMedicineChemotherapyHumansProspective StudiesAgedAged 80 and overCardiotoxicityChemotherapybusiness.industryPreventionFollow up studiesDopplerGeneral MedicineMiddle AgedCardiotoxicityEchocardiography DopplerClinical trialEarly DiagnosisAngiotensin-converting enzyme inhibitorEchocardiography030220 oncology & carcinogenesiscardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: Role of echocardiography

2016

The evaluation by cardiovascular imaging of chemotherapy patients became a central topic in the last several years. The use of drugs for the treatment of cancers increased, and new molecules and protocols were developed to improve outcomes in these patients. Although, these novel approaches also produced a progressive increase in side effects, particularly myocardial dysfunction. Imaging of the heart was highly accurate in the early diagnosis of cancer therapeutics related-cardiac dysfunction. Echocardiography is the first-line method to assess ventricular function alterations, and it is required to satisfy the need for an early, easy and accurate diagnosis to stratify the risk of heart fai…

Cardiac function curvemedicine.medical_specialtymedicine.medical_treatmentLeftEchocardiography Three-DimensionalcardiotoxicityAntineoplastic Agents030204 cardiovascular system & hematologychemotherapycancer cardiotoxicity chemotherapy echocardiographyVentricular Function Left03 medical and health sciences0302 clinical medicineInternal medicineNeoplasmsmedicinecancerHumansVentricular FunctionHeart FailureCardiotoxicityChemotherapyVentricular functionbusiness.industryCancerHeartGeneral Medicinemedicine.diseaseEchocardiography Doppler Colorcancer; cardiotoxicity; chemotherapy; echocardiography; Antineoplastic Agents; Cardiotoxicity; Heart; Heart Failure; Humans; Neoplasms; Ventricular Function Left; Early Diagnosis; Echocardiography Three-Dimensionalcancer; cardiotoxicity; echocardiographyEarly DiagnosisCardiovascular DiseasesEchocardiography030220 oncology & carcinogenesisHeart failureThree-DimensionalCardiologyCardiology and Cardiovascular Medicinebusiness
researchProduct

Renal function and carotid atherosclerosis in adults with no known kidney disease

2017

Abstract Background and aims A high prevalence of atherosclerotic lesions characterizes patients with chronic kidney disease, though there is little data on the relationship between kidney function and atherosclerotic changes in the healthy population or in people with no known renal impairment. The aim of our study was to analyze, in a comprehensive general population with no known kidney disease, the relationship between renal function and subclinical carotid atherosclerotic damage. Methods and results A general real-life population of 611 participants (233 males and 378 females; age ≥18 years) with no known kidney failure was selected for the study. The glomerular filtration rate (GFR) w…

Carotid Artery DiseasesMaleEndocrinology Diabetes and MetabolismMedicine (miscellaneous)030204 cardiovascular system & hematologyKidneyCarotid Intima-Media ThicknessSeverity of Illness IndexCarotid intima-media thicknechemistry.chemical_compound0302 clinical medicineRisk FactorsPrevalenceSettore MED/49 - Scienze Tecniche Dietetiche ApplicateSubclinical infectioneducation.field_of_studyUnivariate analysisKidneyUltrasonography Doppler DuplexNutrition and DieteticsCarotid atherosclerosiMiddle AgedPrognosisCarotid plaquePlaque Atheroscleroticmedicine.anatomical_structureCarotid ArteriesItalycardiovascular systemCardiologyPopulation studyFemaleKidney DiseasesGlomerular filtration rateCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyPopulationRenal function030209 endocrinology & metabolism03 medical and health sciencesPredictive Value of TestsInternal medicinemedicineHumanseducationAgedCreatinineChi-Square Distributionbusiness.industrymedicine.diseaseCross-Sectional StudiesEarly DiagnosischemistryAsymptomatic DiseasesMultivariate AnalysisbusinessKidney disease
researchProduct

Non-coronary atherosclerosis

2014

International audience; During the last decades, the clinical and research interest in atherosclerosis has been mostly focused on coronary arteries. After the publications of the European Society Guidelines and AHA/ACC Guidelines on Peripheral artery diseases, and of the Registry REduction in Atherothrombosis for Continued Health Registry, there has been an increased interest in atherosclerosis of the lower extremity arteries and its presence in multifocal disease. However, awareness in the general population and the medical community of non-coronary artery diseases, and of its major prognostic implications remain relatively low. The aim of this general review stemming out of an ESC Working…

Carotid Artery Diseasesmedicine.medical_specialtyPopulationAortic DiseasesComplex diseaseAorta Thoracic610 Medicine & healthDisease2705 Cardiology and Cardiovascular MedicinePeripheral artery circulationUpper ExtremityRenal ArteryMultifocal diseasemedicineHumansAorta AbdominalPeripheral Artery DiseaseseducationIntensive care medicineCoronary atherosclerosisPeripheral Vascular Diseaseseducation.field_of_studybusiness.industry10031 Clinic for AngiologySettore MED/11 - Malattie Dell'Apparato CardiovascolareMesenteric Arteries3. Good healthCoronary arteriesEarly Diagnosismedicine.anatomical_structureLower ExtremityAtherosclerosiPhysical therapy[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieperipheral artery circulation; atherosclerosisArtery diseasesatherosclerosisCardiology and Cardiovascular Medicinebusiness
researchProduct

[Diagnostic performance of surface electrocardiogram in early detection of chagasic cardiomyopathy].

2013

Contrast-enhanced cardiac magnetic resonance imaging (CMR) allows early detection of myocardial involvement by Trypanosoma cruzi infection. The aim of our study was to assess the diagnostic performance of the surface electrocardiogram (ECG) in the early detection of Chagas' cardiomyopathy (CCM) compared with CMR.We included 43 asymptomatic patients (30 women, 42 ± 9.8 years), diagnosed of Chagas disease. The sample was divided into 2 groups according to the presence (n=17) or absence (n=26) of electrocardiographic abnormalities. All patients underwent CMR and late gadolinium enhancement (LGE) was used as a marker of early myocardial involvement.Six (14%) patients had a LGE significantly hig…

Chagas diseaseAdultChagas CardiomyopathyMalemedicine.medical_specialtyCardiomyopathyEarly detectionAsymptomaticSensitivity and SpecificityElectrocardiographyCardiac magnetic resonance imagingInternal medicinemedicineHumanscardiovascular diseasesAsymptomatic InfectionsRetrospective Studiesmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingSurface electrocardiogramEarly Diagnosiscardiovascular systemCardiologyFemalemedicine.symptombusinessElectrocardiographyMedicina clinica
researchProduct

Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier.

2007

Cognitive deficits in multiple sclerosis (MS) are common and correlate with contemporary MRI brain abnormalities, particularly atrophy, but the ability of imaging early in the disease to predict later cognitive impairment remains to be determined. Thirty relapsing—remitting MS patients recruited within three years of the onset of the disease, and in whom MRI had been performed at baseline and a year later, were assessed neuropsychologically five years later. Imaging parameters accounting for significant variance in cognitive performance were identified using multiple regressions, once confounding variables were controlled. Patients performed significantly worse than expected on tests of at…

Cognitive deficits in multiple sclerosisAdultMalePediatricsmedicine.medical_specialtyDevelopmental psychologyCentral nervous system diseaseDisability EvaluationAtrophyDegenerative diseaseMultiple Sclerosis Relapsing-Remittingrelapsing-remitting multiple sclerosiPredictive Value of TestsmedicineHumansMultiple sclerosiCognitive impairmentMultiple sclerosisCognitive disorderCognitionMiddle Agedmedicine.diseaseMagnetic Resonance ImagingEarly DiagnosisNeurologyRelapsing remittingLinear ModelsFemaleNeurology (clinical)AtrophyPsychologyCognition DisordersFollow-Up StudiesMultiple sclerosis (Houndmills, Basingstoke, England)
researchProduct

Familial hypercholesterolæmia in children and adolescents: Gaining decades of life by optimizing detection and treatment

2015

Contains fulltext : 155263.pdf (Publisher’s version ) (Open Access) Familial hypercholesterolaemia (FH) is a common genetic cause of premature coronary heart disease (CHD). Globally, one baby is born with FH every minute. If diagnosed and treated early in childhood, individuals with FH can have normal life expectancy. This consensus paper aims to improve awareness of the need for early detection and management of FH children. Familial hypercholesterolaemia is diagnosed either on phenotypic criteria, i.e. an elevated low-density lipoprotein cholesterol (LDL-C) level plus a family history of elevated LDL-C, premature coronary artery disease and/or genetic diagnosis, or positive genetic testin…

CounselingEuropean Atherosclerosis Society Consensus PanelPediatricsCardiac & Cardiovascular SystemsSTATIN THERAPYSettore MED/09 - Medicina InternaVascular damage Radboud Institute for Health Sciences [Radboudumc 16]Familial hypercholesterolemiaAdolescentsCarotid Intima-Media ThicknessINTIMA-MEDIA THICKNESSCost of IllnessPregnancyRisk FactorsDiagnosisYOUNG-ADULTSHIPERCOLESTEROLEMIA (DIAGNÓSTICO;TERAPIA;TENDÊNCIAS)Family historyYoung adultChildChildrenEvidence-Based Medicinemedicine.diagnostic_testHomozygoteMiddle AgedFamilial hypercholesterolæmia3. Good healthEconomics MedicalAdolescents; Children; Consensus statement; Diagnosis; Ezetimibe; Familial hypercholesterolæmia; LDL cholesterol; PCSK9 inhibitor; Statin; Treatment; Cardiology and Cardiovascular MedicineCARDIOVASCULAR-DISEASEConsensus statementLDL cholesterolFemalelipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicineFamilial hypercholesterolaemiaLife Sciences & BiomedicineDiagnosimedicine.drugAdultHeterozygotemedicine.medical_specialtyStatinAdolescentmedicine.drug_classPCSK9 inhibitorENDOTHELIAL FUNCTIONLOW-DENSITY-LIPOPROTEINReviewsCOST-EFFECTIVENESS ANALYSIS1102 Cardiovascular Medicine And HaematologyMedication AdherenceHyperlipoproteinemia Type IIYoung AdultLife ExpectancyEzetimibemedicineHumansCORONARY-HEART-DISEASEGenetic TestingGenetic testingPregnancyScience & TechnologyClinical Laboratory Techniquesbusiness.industryPreventionStatinAtherosclerosismedicine.diseaseEzetimibeDietASSOCIATION EXPERT PANELBLOOD-PRESSURE RESEARCHPregnancy ComplicationsTreatmentEarly DiagnosisIntima-media thicknessCardiovascular System & HematologyDietary SupplementsPhysical therapyCardiovascular System & Cardiologybusiness
researchProduct

Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative.

2019

Background: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities. Aim: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify ‘at-risk’ patients who may benefit from diagnostic testing. Methods: An anonymous, three-round Delphi consensus process was deployed among a global panel of 22 specialists in GD (median experience 17.5 years, collectively managin…

Delphi TechniqueDisease outcomethrombocytopeniaMedicina Clínica030204 cardiovascular system & hematology0302 clinical medicine//purl.org/becyt/ford/3.2 [https]Lysosomal storage disease030212 general & internal medicinecomputer.programming_languageGaucher Malaltia de:Ciencias de la información::análisis de sistemas::técnica Delfos [CIENCIA DE LA INFORMACIÓN]lysosomal storage diseaseINBORN ERROR:Information Science::Systems Analysis::Delphi Technique [INFORMATION SCIENCE]Original Article//purl.org/becyt/ford/3 [https]Corrigendum:Diagnosis::Early Diagnosis [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]medicine.medical_specialtyCIENCIAS MÉDICAS Y DE LA SALUDSPLENOMEGALYConsensusPrognosiLYSOSOMAL STORAGE DISEASEMETABOLISMinborn error03 medical and health sciencesPhysiciansInternal MedicinemedicineHumansHematologíaALGORITHM:enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::enfermedades cerebrales metabólicas::enfermedades cerebrales metabólicas congénitas::enfermedades por almacenamiento lisosómico del sistema nervioso::esfingolipidosis::enfermedad de Gaucher [ENFERMEDADES]splenomegalyalgorithmGaucher Diseasebusiness.industryTHROMBOCYTOPENIA:Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Brain Diseases Metabolic::Brain Diseases Metabolic Inborn::Lysosomal Storage Diseases Nervous System::Sphingolipidoses::Gaucher Disease [DISEASES]Original Articlesmedicine.disease:diagnóstico::diagnóstico precoz [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]Early DiagnosisFamily medicinebusinessmetabolismcomputerDelphiInternal medicine journal
researchProduct

Abdominal Compartment Syndrome: diagnostic evaluation and possible treatment

2020

BACKGROUND: Abdominal compartment syndrome (ACS) is a clinical condition caused by an increase in intra-abdominal pressure. The incidence is variable, based on the type of patients taken into consideration, increasing exponentially in critical conditions, such as traumatized, burned patients in shock. The syndrome can also follow surgical procedures like transplantation of abdominal organs, for example configuring rare pictures such as RACS (post-transplant kidney syndrome). In most cases the symptoms are non-specific and varied according to the different etiology of the ACS, therefore the diagnosis may not be immediate. AIM: The aim of this work is to evaluate the best therapeutic approach…

Early DiagnosisRenal Allograft Compartment SyndromeIncidenceHumansAbdomen decompressionIntra-Abdominal HypertensionDecompression SurgicalSurgical emergency
researchProduct

Early diagnosis of primary melanoma of caecum. Case report and review of the literature.

2021

Malignant gastrointestinal melanoma is usually a metastatic lesion. We report the case of a 79-year-old female asymptomatic patient. Colonoscopy revealed one plane 15 mm pigmented lesion in the caecum. Neither CT scan of the abdomen nor right hemicolectomy revealed no metastatic disease. Histopathological examination of the surgical specimen was indicative of malignant melanoma.A set of additional enquires such as laboratory and imaging tests did not point out any suspicious lesions in the skin, eye, leptomeninges or other sites. Therefore, we made the diagnosis of primary colonic melanoma.The diagnosis of this disease is still a challange and often demanding for a multidisciplinary approac…

Early DiagnosisSkin NeoplasmsHumansFemaleCecumMelanomaColectomyAgedActa bio-medica : Atenei Parmensis
researchProduct